{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:40:03Z","timestamp":1738978803287,"version":"3.37.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/scs.0b013e3180534453","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:03:56Z","timestamp":1236215036000},"page":"1353-1358","source":"Crossref","is-referenced-by-count":2,"title":["Comparison Among Clark's, Breslow's, and TNM Classifications for Cutaneous Head and Neck Malignant Melanoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Paolo","family":"Morselli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Masciotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Zollino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Carinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210208","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.0.CO;2-7","article-title":"Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.","volume":"83","author":"Quinn","year":"1998","journal-title":"Cancer"},{"key":"R2-18-20210208","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1085-5629(96)80047-2","article-title":"Neoplastic progression and prognosis in melanoma.","volume":"15","author":"Elder","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"R3-18-20210208","doi-asserted-by":"crossref","first-page":"342S","DOI":"10.1038\/jid.1993.60","article-title":"Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.","volume":"100","author":"Guerry","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R4-18-20210208","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression.","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R5-18-20210208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000637-199201000-00021","article-title":"Metastatic melanoma with an unknown primary.","volume":"28","author":"Normal","year":"1992","journal-title":"Ann Plast Surg"},{"key":"R6-18-20210208","first-page":"650","article-title":"Melanoma and sun exposure.","volume":"23","author":"Elwood","year":"1996","journal-title":"Semin Oncol"},{"key":"R7-18-20210208","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","article-title":"Cancer statistics, 1998.","volume":"48","author":"Landis","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"R8-18-20210208","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1200\/JCO.2006.06.1325","article-title":"Anatomic site, sun exposure, and risk of cutaneous melanoma.","volume":"24","author":"Whiteman","year":"2006","journal-title":"J Clin Oncol"},{"key":"R9-18-20210208","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/oxfordjournals.aje.a117092","article-title":"Case-control study of malignant melanoma in Washington State. Part I. Constitutional factors and sun exposure.","volume":"139","author":"White","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R10-18-20210208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1097-0347(199603\/04)18:2<107::AID-HED1>3.0.CO;2-5","article-title":"Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck.","volume":"18","author":"Austin","year":"1996","journal-title":"Head Neck"},{"key":"R11-18-20210208","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"R12-18-20210208","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02303495","article-title":"Surgical margins and prognostic factors in patients with thick (4 mm) primary melanoma.","volume":"5","author":"Heaton","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"R13-18-20210208","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin.","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"R15-18-20210208","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00008390-200504000-00006","article-title":"Increased incidence of brain metastases in cutaneous head and neck melanoma.","volume":"15","author":"Daryanani","year":"2005","journal-title":"Melanoma Res"},{"key":"R16-18-20210208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/107327480501200406","article-title":"Head and neck melanoma.","volume":"12","author":"Kienstra","year":"2005","journal-title":"Cancer Control"},{"key":"R17-18-20210208","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<272::AID-SSU2>3.0.CO;2-#","article-title":"Margin of resection in the management of primary melanoma.","volume":"14","author":"Cascinelli","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"R18-18-20210208","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","article-title":"Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial.","volume":"218","author":"Balch","year":"1993","journal-title":"Ann Surg"},{"key":"R19-18-20210208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.2890050303","article-title":"Melanoma of the head and neck in Qeensland.","volume":"5","author":"Harris","year":"1983","journal-title":"Head Neck Surg"},{"key":"R20-18-20210208","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/02844310410004883","article-title":"Reconstructive considerations after resection of malignant melanoma in the head and neck.","volume":"39","author":"Sekido","year":"2005","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"R21-18-20210208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma.","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"R22-18-20210208","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9610(98)00262-1","article-title":"Sentinel lymph node biopsy for melanoma.","volume":"176","author":"Gogel","year":"1998","journal-title":"Am J Surg"},{"key":"R23-18-20210208","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jso.20554","article-title":"Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome?","volume":"93","author":"Doting","year":"2006","journal-title":"J Surg Oncol"},{"key":"R24-18-20210208","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cncr.11921","article-title":"Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.","volume":"100","author":"Bonnen","year":"2004","journal-title":"Cancer"},{"key":"R25-18-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"R26-18-20210208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/oxfordjournals.annonc.a010762","article-title":"Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.","volume":"7","author":"Legha","year":"1996","journal-title":"Ann Oncol"},{"key":"R27-18-20210208","first-page":"3075","article-title":"A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.","volume":"8","author":"Atkins","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R28-18-20210208","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1200\/JCO.1998.16.5.1743","article-title":"Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.","volume":"16","author":"Falkson","year":"1998","journal-title":"J Clin Oncol"},{"key":"R29-18-20210208","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1200\/JCO.1997.15.7.2579","article-title":"Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.","volume":"15","author":"Keilholz","year":"1997","journal-title":"J Clin Oncol"},{"key":"R30-18-20210208","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1200\/JCO.1999.17.3.968","article-title":"Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.","volume":"17","author":"Rosenberg","year":"1999","journal-title":"J Clin Oncol"},{"key":"R31-18-20210208","first-page":"53","article-title":"Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines: principles and future prospects.","volume":"4","author":"Fernandez","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"R32-18-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00008390-199602000-00003","article-title":"New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.","volume":"6","author":"Maeurer","year":"1996","journal-title":"Melanoma Res"},{"key":"R33-18-20210208","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1098-2388(199611\/12)12:6<446::AID-SSU10>3.0.CO;2-T","article-title":"Tumor antigens and tumor vaccines: peptides as immunogens.","volume":"12","author":"Slingluff","year":"1996","journal-title":"Semin Surg Oncol"},{"key":"R34-18-20210208","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2249.2005.02948.x","article-title":"Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.","volume":"142","author":"Escobar","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R35-18-20210208","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/00005537-200009000-00017","article-title":"A prospective population-based study of cutaneous malignant melanoma of the head and neck.","volume":"110","author":"Gillgren","year":"2000","journal-title":"Laryngoscope"},{"key":"R36-18-20210208","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1097-0142(19930201)71:3<751::AID-CNCR2820710317>3.0.CO;2-9","article-title":"Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.","volume":"71","author":"Ringborg","year":"1993","journal-title":"Cancer"},{"key":"R37-18-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.2006.07455.x","article-title":"Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.","volume":"155","author":"Hoersch","year":"2006","journal-title":"Br J Dermatol"},{"key":"R38-18-20210208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0347(200101)23:1<8::AID-HED2>3.0.CO;2-F","article-title":"The role of soft tissue reconstruction after melanoma resection in the head and neck.","volume":"23","author":"Bogle","year":"2001","journal-title":"Head Neck"},{"key":"R39-18-20210208","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/02844318209006584","article-title":"The use of skin flaps in the treatment of malignant melanomas in the head and neck region.","volume":"16","author":"Frokiaer","year":"1982","journal-title":"Scand J Plast Reconstr Surg"},{"key":"R40-18-20210208","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1158\/1055-9965.EPI-04-0632","article-title":"Risk factors for melanoma by body site.","volume":"14","author":"Cho","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Craniofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001665-200711000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:04:03Z","timestamp":1738976643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001665-200711000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/scs.0b013e3180534453","relation":{},"ISSN":["1049-2275"],"issn-type":[{"type":"print","value":"1049-2275"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}